VIRX
Viracta Therapeutics, Inc.
OTCHealthcareBiotechnologyUS
Company Profile
CEO
Craig R. Jalbert
IPO Date
2005-09-27
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Viracta Therapeutics, Inc.
CEO
Craig R. Jalbert
IPO Date
2005-09-27
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
| 25,219 |
| $0.00 |
| 27 Nov 2024 | Pomerantz Roger | director | M-Exempt | Acquired | 9,034 | $0.00 |
| 27 Nov 2024 | Pomerantz Roger | director | M-Exempt | Disposed | 9,034 | $0.00 |
| 12 Sept 2024 | ROYSTON IVOR | director | M-Exempt | Acquired | 25,219 | $0.00 |
| 12 Sept 2024 | ROYSTON IVOR | director | M-Exempt | Disposed | 25,219 | $0.00 |
| 12 Sept 2024 | Pomerantz Roger | director | M-Exempt | Acquired | 9,034 | $0.00 |
| 12 Sept 2024 | Pomerantz Roger | director | M-Exempt | Disposed | 9,034 | $0.00 |
| 24 Jun 2024 | ROYSTON IVOR | director | A-Award | Acquired | 50,000 | $0.57 |
| 24 Jun 2024 | Simon Barry J. | director | A-Award | Acquired | 50,000 | $0.57 |